LAFFI, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.680
EU - Europa 14.186
AS - Asia 8.025
SA - Sud America 982
AF - Africa 235
OC - Oceania 165
Continente sconosciuto - Info sul continente non disponibili 95
Totale 46.368
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.332
RU - Federazione Russa 4.609
IT - Italia 2.564
SG - Singapore 2.220
PL - Polonia 2.043
CN - Cina 1.655
HK - Hong Kong 1.462
SE - Svezia 1.230
IE - Irlanda 1.136
VN - Vietnam 892
BR - Brasile 794
KR - Corea 752
DE - Germania 603
UA - Ucraina 555
FI - Finlandia 428
FR - Francia 387
GB - Regno Unito 292
IN - India 239
CA - Canada 221
JP - Giappone 194
AU - Australia 163
JO - Giordania 113
TR - Turchia 106
BD - Bangladesh 90
CH - Svizzera 87
NL - Olanda 71
CI - Costa d'Avorio 60
AR - Argentina 57
ID - Indonesia 52
MX - Messico 44
BE - Belgio 43
IQ - Iraq 42
NG - Nigeria 38
EC - Ecuador 35
CO - Colombia 34
ES - Italia 33
ZA - Sudafrica 32
PK - Pakistan 29
MA - Marocco 24
UZ - Uzbekistan 24
EG - Egitto 23
AE - Emirati Arabi Uniti 20
SC - Seychelles 19
VE - Venezuela 19
SA - Arabia Saudita 16
JM - Giamaica 14
CR - Costa Rica 13
CL - Cile 12
HN - Honduras 12
AZ - Azerbaigian 11
PE - Perù 11
PH - Filippine 11
AL - Albania 10
AT - Austria 10
CZ - Repubblica Ceca 10
MY - Malesia 10
PY - Paraguay 10
KE - Kenya 9
TT - Trinidad e Tobago 9
BG - Bulgaria 8
DZ - Algeria 8
PT - Portogallo 8
TH - Thailandia 8
TN - Tunisia 7
KZ - Kazakistan 6
LT - Lituania 6
LV - Lettonia 6
NP - Nepal 6
RO - Romania 6
SV - El Salvador 6
SY - Repubblica araba siriana 6
AM - Armenia 5
BO - Bolivia 5
DK - Danimarca 5
GT - Guatemala 5
HU - Ungheria 5
IL - Israele 5
KG - Kirghizistan 5
LB - Libano 5
NI - Nicaragua 5
OM - Oman 5
PA - Panama 5
PS - Palestinian Territory 5
TW - Taiwan 5
UY - Uruguay 5
BY - Bielorussia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
BB - Barbados 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GR - Grecia 3
IR - Iran 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
MM - Myanmar 3
MT - Malta 3
NO - Norvegia 3
PR - Porto Rico 3
Totale 46.233
Salva come PNG Salva come JPEG
Città #
Santa Clara 4.455
Ashburn 2.065
Warsaw 2.034
Fairfield 1.881
Singapore 1.512
Hong Kong 1.206
Chandler 1.190
San Jose 1.142
Dublin 1.135
Jacksonville 892
Woodbridge 840
Cambridge 776
Seattle 773
Seoul 746
Houston 655
Wilmington 642
Milan 574
Beijing 537
Los Angeles 402
Ann Arbor 369
Council Bluffs 333
Buffalo 318
Princeton 288
The Dalles 284
Ho Chi Minh City 267
Lauterbourg 241
Boston 231
Boardman 229
Rome 225
Hanoi 212
Lawrence 207
Altamura 203
Dallas 200
Tokyo 176
Melbourne 161
Florence 153
Hefei 145
Mumbai 131
Munich 126
Moscow 120
New York 117
Medford 111
Phoenix 109
San Diego 108
Helsinki 100
Shanghai 91
Bern 85
Paris 81
Columbus 74
Naples 71
Bremen 69
Izmir 67
São Paulo 65
Turku 61
Abidjan 60
London 57
Norwalk 57
Kent 51
Bologna 48
Turin 48
Toronto 45
Bari 44
Redondo Beach 44
Frankfurt am Main 43
Orem 43
Da Nang 42
Montreal 40
Chicago 38
Verona 38
Guangzhou 37
Abuja 36
Brussels 34
Brooklyn 33
Haiphong 33
Dong Ket 32
Hillsboro 32
Palermo 31
Andover 30
Jakarta 30
Falls Church 28
Washington 28
Auburn Hills 26
Miano 24
Chennai 23
Tashkent 23
Figino 22
Salerno 22
Yubileyny 22
Stockholm 21
Atlanta 20
Belo Horizonte 20
Clifton 20
Dearborn 20
Genoa 20
Rio de Janeiro 20
San Francisco 20
Hải Dương 19
Manchester 19
Biên Hòa 18
Denver 18
Totale 30.764
Salva come PNG Salva come JPEG
Nome #
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis 383
Complete resolution of primary sclerosing peritonitis ("abdominalCocoon") following long term therapy for tropheryma whipplei: a case report and review of literature. 373
Effect of some cyclooxygenase inhibitors on the increase in guanosine 3':5'-cyclic monophosphate induced by NO-donors in human whole platelets. 359
Acute on chronic liver failure: From pathophysiology to clinical management. 349
Macro-aspartate aminotransferase in a healthy woman 335
Differential expression of two isoforms of the chemokine receptor CXCR3 determines the ultimate effect of IP-10 on survival of human hepatic stellate cells (HSC) 327
Evaluation of the prognostic value of liver stiffness in patients with hepatitis C virus treated with triple or dual antiviral therapy: A prospective pilot study 325
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. 323
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 321
Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature. 319
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study 315
Neuroendocrine dysregulation in irritable bowel syndrome patients: A pilot study 311
Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment. 306
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 288
Aldoxorubicin and Temozolomide combination in a xenograft mice model of human glioblastoma. 281
Tumor response of temozolomide in combination with morphine in a xenograft model of human glioblastoma 276
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 273
Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A. 268
HCV Patients Psychopathology and Tryptophan Metabolism: Analysis of the Effects of Pegylated Interferon plus Ribavirin Treatment 264
D-dimer and fibrinolytic activity in patients with liver cirrhosis and ascites. Preliminary results. 254
Acute viral hepatitis increases liver stiffness values measured by transient elastography 247
The kinin system and other vasoactive substances in chronic liver disease. 246
[Renal function in chronic hepatopathies] 243
[Some aspects of the physiopathology of renal insufficiency in the course of chronic liver diseases] 238
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis 237
THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS 234
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C 229
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 227
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. 227
Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis. 223
Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells. 223
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis 222
Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells 222
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia 219
Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis. 217
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice 214
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 214
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 214
Host genetic determinants in HCV-related mixed cryoglobulinemia 213
ADMA correlates with portal pressure in patients with compensated cirrhosis. 209
DRESS syndrome in a patient with chronic hepatic encephalopathy. 209
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open-label, cohort study. 208
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 205
Plasma levels of brain natriuretic peptide in patients with cirrhosis. 204
Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study 204
Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany 203
Host genetic determinants in HCV-related mixed cryoglobulinemia 201
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 200
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 200
THROMBOPOIETIN STIMULATES MIGRATION AND INVASION OF HepG2 CELLS. 199
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. 198
Altered platelet function in cirrhosis of the liver: impairment of inositol lipid and arachidonic acid metabolism in response to agonists 197
Expression of IP-10 and its receptor CXCR3 in hepatic stellate cells identifies a novel autocrine and paracrine system. 196
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 195
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 195
Analysis of HCV persistence in patients with sustained virological response 195
Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance 195
EFFECTS OF NITRIC OXIDE (NO)-DONORS ON ACTIVATED HUMAN HEPATIC STELLATE CELLS (HSC): CELLULAR BASIS FOR THE TREATMENT OF PORTAL HYPERTENSION. 194
Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: A preliminary study 194
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. 194
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 194
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 193
Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. 192
Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. 192
Acute effect of furosemide on renal kallikrein and prostaglandin systems in mild to moderate essential hypertension. 191
Defective aggregation in cirrhosis is independent of in vivo platelet activation. 191
Functional insufficiency in chronic liver disease patients. The hepatorenal syndrome 190
Cardiovascular effects of canrenone in patients with preascitic cirrhosis 189
Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. 189
Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion. 188
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 188
Cardiac and renal response to posture in cirrhotics with and without essential hypertension 187
ALBUMIN IMPROVES RESPONSE TO DIURETICS IN DECOMPENSATED CIRRHOTIC PATIENTS. 186
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. 186
Nuclear localization of TRK-A in liver cells. 185
Functional renal alterations in chronic liver diseases. 185
[Hearing threshold of workers not exposed to occupational noise: reference values] 184
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial 184
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C. 184
Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury. 184
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 183
Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab 183
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C 182
Increased plasma carbon monoxide in patients with viral cirrhosis and hyperdynamic circulation. 182
Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclo-oxygenase metabolites in hepatic stellate cells 182
Screening of distress among hospitalized patients in a department of internal medicine. 181
Age-dependent association of exposure to television screen with children's urinary melatonin excretion? 181
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 180
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 180
Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients 179
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 179
Loop diuretic therapy in liver cirrhosis with ascites 178
Characterization of lymphocyte subsets in ascitic fluid and peripheral blood of decompensated cirrhotic patients with chronic hepatitis C and alcoholic liver disease: A pivotal study 178
Adiponectin and the cardiovascular system: from risk to disease. 178
Activation of focal adhesion kinase by PDGF is dependent on Ras in human hepatic stellate cells 177
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 177
Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. 177
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 176
microRNA PROFILE MODIFICATIONS IN HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA 176
Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation 175
Totale 22.100
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.780
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.780
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.610 0 0 92 79 69 71 76 111 92 63 402 555
2022/20235.035 466 677 269 386 451 938 673 312 569 24 146 124
2023/20241.593 68 209 306 91 102 231 45 357 22 45 56 61
2024/202512.374 411 1.269 829 1.929 3.966 1.413 124 784 607 293 397 352
2025/202612.517 1.527 1.683 772 1.086 1.329 403 1.411 526 999 720 246 1.815
2026/20271.613 375 481 757 0 0 0 0 0 0 0 0 0
Totale 46.368